Unichem Laboratories Limited
NSE: UNICHEMLAB BSE: UNICHEMLAB
NSE
630.20
-17.95 (-2.77%)
Prev Close
648.15
Open Price
638.45
Volume
16,174
Today Low / High
624.2 / 642.55
52 WK Low / High
472.75 / 937.95
Range
599 - 662
BSE
630.00
-15.90 (-2.46%)
Prev Close
645.9
Open Price
637.15
Volume
1,929
Today Low / High
624.25 / 641.85
52 WK Low / High
433.25 / 949.85
Range
599 - 662
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 630.2 (target range: 599 - 662), reflecting a change of -17.95 (-2.76942%). On the BSE, it is listed at 630 (target range: 599 - 662), showing a change of -15.9 (-2.46168%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
04 Mar
638.45
-1.31%
03 Mar
615.00
5.39%
28 Feb
618.80
-2.24%
27 Feb
654.00
-5.02%
25 Feb
651.10
-1.20%
24 Feb
675.05
-2.86%
21 Feb
700.50
-1.76%
20 Feb
691.00
1.37%
19 Feb
660.00
5.27%
18 Feb
670.10
-1.45%
17 Feb
688.05
-2.49%
14 Feb
695.10
-1.22%
13 Feb
689.40
0.67%
12 Feb
701.10
-0.17%
11 Feb
709.50
-0.20%
10 Feb
722.25
-1.09%
07 Feb
739.95
-1.41%
06 Feb
732.00
0.16%
05 Feb
724.35
-0.14%
04 Feb
721.00
-0.52%
Unichem Laboratories Limited Graph
Unichem Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking Target Price for Unichem Laboratories Limited T1, T2, T3, for both Bullish or Bearish. For Bullish T1, T2, T3 and for Bearish T1, T2, T3. The stock current price is 630, with potential price targets ranging from T1, T2, T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 630.00 | 636.30 | 572.67 - 699.93 |
| 642.60 | 514.08 - 771.12 | ||
| 648.90 | 454.23 - 843.57 | ||
| Bearish Scenario | 630.00 | 623.70 | 561.33 - 686.07 |
| 617.40 | 493.92 - 740.88 | ||
| 611.10 | 427.77 - 794.43 |
Overview of Unichem Laboratories Limited
ISIN
INE351A01035
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
46,418
Market Cap
44,380,296,030
Last Dividend
0
Official Website
IPO Date
2002-07-01
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Stock Dividend of UNICHEMLAB
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2022-08-01 | August 01, 22 | 4 | 4 | 2022-08-02 | 2022-08-20 | |
| 2021-07-22 | July 22, 21 | 4 | 4 | 2021-07-24 | 2021-08-30 | |
| 2020-08-20 | August 20, 20 | 4 | 4 | 2020-08-22 | 2020-09-04 | |
| 2019-07-18 | July 18, 19 | 4 | 4 | 2019-07-20 | 2019-08-02 | |
| 2018-07-19 | July 19, 18 | 5 | 5 | 2018-07-21 | 2018-08-03 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 1,657.42 Cr | 1,339.98 Cr | 317.43 Cr | 0.1915 | 104.67 Cr | 43.29 Cr | -12.99 Cr | -70.47 Cr | -10.01 | 74.24 Cr | -0.0425 |
| 2023-03-31 | 1,343.02 Cr | 550.93 Cr | 792.10 Cr | 0.5898 | 26.39 Cr | 33.32 Cr | -150.61 Cr | -202.23 Cr | -28.73 | -46.67 Cr | -0.1506 |
| 2022-03-31 | 1,247.98 Cr | 440.54 Cr | 807.44 Cr | 0.6470 | 33.76 Cr | 32.48 Cr | -11.14 Cr | 33.06 Cr | 4.70 | 118.22 Cr | 0.0265 |
| 2021-03-31 | 1,189.92 Cr | 401.37 Cr | 788.55 Cr | 0.6627 | 43.90 Cr | 36.42 Cr | 7.28 Cr | 34.32 Cr | 4.88 | 141.23 Cr | 0.0288 |
| 2020-03-31 | 1,156.49 Cr | 409.40 Cr | 747.10 Cr | 0.6460 | 156.41 Cr | 49.34 Cr | -130.59 Cr | -60.18 Cr | -8.55 | 40.49 Cr | -0.0520 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 150.91 Cr | 3,169.34 Cr | 806.93 Cr | 2,362.4188 Cr | 247.51 Cr | 96.60 Cr | 704.68 Cr | 1,324.21 Cr | 7.69 Cr | 0.87 Cr | -1.32 Cr | 707.8787 Cr |
| 2023-03-31 | 183.75 Cr | 3,193.05 Cr | 757.74 Cr | 2,435.3041 Cr | 314.05 Cr | 130.29 Cr | 625.23 Cr | 1,402.57 Cr | 58.12 Cr | 1.10 Cr | 1.62 Cr | 639.6008 Cr |
| 2022-03-31 | 109.20 Cr | 3,318.77 Cr | 700.36 Cr | 2,618.4110 Cr | 349.15 Cr | 239.96 Cr | 600.22 Cr | 1,482.30 Cr | 70.72 Cr | 4.69 Cr | -260.62 Cr | 552.1277 Cr |
| 2021-03-31 | 77.46 Cr | 3,125.71 Cr | 568.88 Cr | 2,556.8348 Cr | 119.09 Cr | 41.63 Cr | 538.34 Cr | 1,446.37 Cr | 134.27 Cr | 4.69 Cr | -80.84 Cr | 505.7611 Cr |
| 2020-03-31 | 226.22 Cr | 3,144.74 Cr | 613.38 Cr | 2,531.3517 Cr | 206.51 Cr | -19.71 Cr | 396.54 Cr | 1,194.98 Cr | 102.14 Cr | 4.69 Cr | -288.32 Cr | 566.7265 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 16.6940 Cr | 50.4043 Cr | -106.3113 Cr | -5.8533 Cr | -32.8398 Cr | 150.9124 Cr | -22.5473 Cr | -70.4743 Cr | -78.4796 Cr | -0.2135 Cr | -79.4469 Cr |
| 2023-03-31 | -85.0907 Cr | 202.8133 Cr | -81.2999 Cr | -129.4064 Cr | 74.5559 Cr | 183.7522 Cr | -44.3157 Cr | -176.3629 Cr | -33.3557 Cr | -28.2545 Cr | -25.0078 Cr |
| 2022-03-31 | -259.6120 Cr | 100.1193 Cr | 191.2282 Cr | -386.6144 Cr | 31.7355 Cr | 109.1963 Cr | -127.0024 Cr | 21.9689 Cr | 109.8250 Cr | -28.3615 Cr | -61.8817 Cr |
| 2021-03-31 | 33.0987 Cr | -73.5576 Cr | -121.1911 Cr | -254.7157 Cr | -154.0576 Cr | 77.4608 Cr | -287.8144 Cr | 51.4794 Cr | -83.4086 Cr | -28.6579 Cr | -141.7988 Cr |
| 2020-03-31 | 19.8165 Cr | -41.2108 Cr | -62.2995 Cr | -366.3355 Cr | 29.1732 Cr | 226.2199 Cr | -386.1520 Cr | -48.2102 Cr | -16.5898 Cr | -34.0336 Cr | -57.8764 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 533.09 Cr | 191.52 Cr | 341.57 Cr | 0.6407 | 0.00 Cr | 57.85 Cr | 8.22 | 99.14 Cr | 0.1085 |
| 2024-09-30 | 462.16 Cr | 174.48 Cr | 287.68 Cr | 0.6225 | 28.99 Cr | 30.49 Cr | 4.34 | 66.32 Cr | 0.0660 |
| 2024-06-30 | 446.43 Cr | 287.39 Cr | 159.04 Cr | 0.3562 | 161.65 Cr | 9.26 Cr | 1.31 | 43.50 Cr | 0.0207 |
| 2024-03-31 | 431.70 Cr | 293.47 Cr | 138.23 Cr | 0.3202 | -127.43 Cr | -129.31 Cr | -18.37 | -94.12 Cr | -0.2995 |
| 2023-12-31 | 434.38 Cr | 166.49 Cr | 267.89 Cr | 0.6167 | 21.53 Cr | 83.99 Cr | 11.93 | 117.41 Cr | 0.1934 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 187.78 Cr | 10.64 Cr | 198.42 Cr | 0.00 Cr | 837.46 Cr | 1,823.47 Cr | 1,296.43 Cr | 3,310.96 Cr | 910.31 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 152.25 Cr | 0.00 Cr | 0.00 Cr | 152.25 Cr | 0.00 Cr | 0.00 Cr | -2,362.42 Cr |
| 2024-03-31 | 154.32 Cr | 1.34 Cr | 155.66 Cr | 619.10 Cr | 704.68 Cr | 1,694.16 Cr | 1,317.14 Cr | 3,169.34 Cr | 806.93 Cr |
| 2023-12-31 | -66.14 Cr | 132.28 Cr | 66.14 Cr | 0.00 Cr | 0.00 Cr | 66.14 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 63.14 Cr | 3.71 Cr | 66.85 Cr | 0.00 Cr | 637.54 Cr | 1,532.29 Cr | 1,347.22 Cr | 3,069.93 Cr | 661.92 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 9.26 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -129.31 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 83.99 Cr | 55.72 Cr | 0.00 Cr | 0.00 Cr | 55.72 Cr | 120.27 Cr | 64.56 Cr | 0.00 Cr | 55.72 Cr |
| 2023-09-30 | -24.49 Cr | 58.91 Cr | 0.00 Cr | 0.00 Cr | 58.91 Cr | 64.56 Cr | 5.65 Cr | 0.00 Cr | 58.91 Cr |
| 2023-06-30 | -0.67 Cr | 57.54 Cr | 0.00 Cr | 0.00 Cr | 57.54 Cr | 242.79 Cr | 185.25 Cr | 0.00 Cr | 57.54 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2010-10-21 | October 21, 10 | 2:1 |
| 2004-03-16 | March 16, 04 | 2:1 |
| 2001-07-03 | July 03, 01 | 2:1 |
| 2000-04-03 | April 03, 00 | 2:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,564.00 | ₹3,752,473,920,000.00 | ₹819,184.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹5,517.70 | ₹1,464,778,301,300.00 | ₹68,160.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹2,956.50 | ₹1,000,612,642,500.00 | ₹190,315.00 |
| Mankind Pharma Limited | MANKIND | ₹2,295.75 | ₹947,177,137,290.00 | ₹185,146.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,116.50 | ₹930,158,405,330.00 | ₹456,090.00 |
| Lupin Limited | LUPIN | ₹1,937.00 | ₹884,203,697,000.00 | ₹273,267.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹871.00 | ₹876,426,330,000.00 | ₹366,181.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,052.20 | ₹611,119,864,400.00 | ₹423,064.00 |
| Alkem Laboratories Limited | ALKEM | ₹4,598.90 | ₹549,867,478,500.00 | ₹28,016.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,314.00 | ₹370,795,032,000.00 | ₹100,851.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,344.00 | ₹340,978,176,000.00 | ₹58,197.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,451.00 | ₹306,159,312,000.00 | ₹62,432.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,169.85 | ₹297,802,865,250.00 | ₹195,094.00 |
| Laurus Labs Limited | LAURUSLABS | ₹542.40 | ₹292,490,827,200.00 | ₹1,286,411.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,617.85 | ₹251,747,167,100.00 | ₹30,570.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,235.30 | ₹200,694,249,800.00 | ₹290,019.00 |
| Piramal Enterprises Limited | PEL | ₹878.50 | ₹198,082,423,000.00 | ₹178,739.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹7,243.15 | ₹181,078,750,000.00 | ₹28,575.00 |
| Eris Lifesciences Limited | ERIS | ₹1,189.55 | ₹161,932,251,950.00 | ₹22,890.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹783.20 | ₹153,948,141,600.00 | ₹340,040.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹922.00 | ₹146,857,082,000.00 | ₹74,107.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹11,269.70 | ₹144,589,124,030.00 | ₹40,990.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹802.35 | ₹143,708,908,500.00 | ₹592,942.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,790.10 | ₹136,068,544,170.00 | ₹355,947.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹474.35 | ₹115,027,028,900.00 | ₹795,621.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,123.60 | ₹85,048,685,840.00 | ₹2,131.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹734.75 | ₹66,587,460,848.00 | ₹187,301.00 |
| FDC Limited | FDC | ₹379.30 | ₹61,753,833,000.00 | ₹79,967.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹624.80 | ₹61,099,754,320.00 | ₹169,383.00 |
| Strides Pharma Science Limited | STAR | ₹608.65 | ₹56,094,827,355.00 | ₹178,673.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹913.85 | ₹46,349,649,535.00 | ₹64,084.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹630.20 | ₹44,369,735,160.00 | ₹16,174.00 |
| Hikal Limited | HIKAL | ₹356.20 | ₹43,919,816,200.00 | ₹112,488.00 |
| Innova Captab Limited | INNOVACAP | ₹680.35 | ₹38,932,981,126.00 | ₹67,737.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹116.41 | ₹37,777,606,020.00 | ₹905,493.00 |
| Sequent Scientific Limited | SEQUENT | ₹145.71 | ₹36,471,504,420.00 | ₹552,201.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,099.85 | ₹34,729,419,150.00 | ₹13,910.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹348.00 | ₹31,761,960,000.00 | ₹53,740.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹315.85 | ₹31,672,806,300.00 | ₹62,133.00 |
| Suven Life Sciences Limited | SUVEN | ₹116.20 | ₹25,340,198,800.00 | ₹396,197.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹45.69 | ₹25,036,018,260.00 | ₹2,462,853.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹469.95 | ₹23,658,234,649.00 | ₹102,097.00 |
| Alembic Limited | ALEMBICLTD | ₹89.81 | ₹23,061,591,330.00 | ₹324,492.00 |
| Indoco Remedies Limited | INDOCO | ₹226.52 | ₹20,895,994,308.00 | ₹231,630.00 |
| Bajaj HealthCare Limited | BAJAJHCARE | ₹645.70 | ₹20,393,336,810.00 | ₹306,008.00 |
Key Executives
Chief Manufacturing & Compliance Officer
Dr. Ashwani Kumar
Gender: Not Specified
Year Born:
Head of Legal, Company Secretary & Compliance Officer
Mr. Pradeep Kumar Bhandari
Gender: male
Year Born: 1958
President of North America & Chief Executive Officer of North America
Mr. Scott B. Delaney
Gender: male
Year Born: 1969
MD & Director
Mr. Pabitra Kumar Kalipada Bhattacharya
Gender: male
Year Born: 1969
Chief Executive of Domestic Pharma
Mr. Bhagwat S. Dhingra
Gender: male
Year Born: 1963
Chief Quality & Compliance Officer
Mr. Jalesh Burye
Gender: male
Year Born:
Vice President of Chemical of Research and Development
Dr. P. B. Deshpande M.Sc. Ph.D.
Gender: Not Specified
Year Born: 1955
Chief Scientific & Compliance Officer
Dr. Dhananjay Sathe
Gender: Not Specified
Year Born:
Head of Projects & Investments
Mr. Vinod Kumar Behl
Gender: male
Year Born: 1950
Vice President of Human Resources & ER
Mr. Prasad Joshi
Gender: male
Year Born: 1958
FAQs about Unichem Laboratories Limited
Who is the CEO of the company?
The CEO is Mr. Scott B. Delaney.
What is the current market price of the stock?
The current price is ₹630.35.
What is the 52-week price range?
The range is ₹472.75-937.95.
What is the market capitalization of the company?
The market capitalization is ₹4,438.03 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -139.89.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Unichem Laboratories Limited (ISIN: INE351A01035) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹4,438.03 crores and an average daily volume of 46,418 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.